Global Medical Biomimetics Market, By Product Type (Cardiovascular, Ophthalmology, Dental, Orthopedic, and Others), Application (Wound Healing, Plastic Surgery, Drug Delivery, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was estimated at US$ 26.2 billion in 2019 and is projected to exhibit a CAGR of 6.5% over the forecast period (2020–2027), as highlighted in a new report published by Coherent Market Insights.
Request FREE Sample – https://www.coherentmarketinsights.com/insight/request-sample/3786
The increasing incidence of cardiovascular disorders to fuel growth of the global medical biomimetics market
According to a report published by the Centers for Diseases Control and Prevention in 2017, heart disease is the leading cause of death for men in the U.S. and an estimated 18.2 million adults aged 20 and older have CAD (Coronary Artery Disease).
Moreover, research and development of products along with investments in the healthcare sector in developing and developed economies of the world are also expected to propel the growth of the medical biomimetics market during the forecast period. According to research published in the International Journal of Molecular Sciences in 2019, gelatin/hydroxyapatite microsphere (GHM) was used to embed stromal cell-derived factor-1 (SDF-1), a well-characterized chemokine for attracting stem cells and a strong candidate for promoting bone regeneration.
Furthermore, adoption of expansion strategies such as entry into new market from manufactures is also anticipated to drive the growth of global Medical Biomimetics market during the forecast period. For instance, on February 2020, Osteopore International Pte Ltd., a producer of 3D-printed bioresorbable implants to assist with natural tissue regeneration, announced plans to enter markets in China and the U.S.
Get Discount For First Time Buyers
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3786
The increasing prevalence of non-communicable diseases (NCDs) is driving demand for medical biomimetics products. For instance, according to the World Health Organization’s 2018 reports, heart disease, stroke, cancer, diabetes and chronic lung disease are collectively responsible for almost 70% of all deaths worldwide. Therefore, to cope up with rising disease incidence, manufactures are focused on expanding their portfolio and geographical reach through product launches and approvals.
Key players in the market are focused on adopting expansion strategies to increase their product portfolio and strengthen their position in the global medical biomimetics market. For instance, in November 2019, Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, announced the opening of a new production facility in Gaithersburg, Maryland, U.S.
Browse 26 Market Data Tables and 18 Figures spread through 145 Pages and in-depth TOC on ‘Medical Biomimetics Market’- Global Forecast to 2027, By Product Type (Cardiovascular, Ophthalmology, Dental, Orthopedic, and Others), Application (Wound Healing, Plastic Surgery, Drug Delivery, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
To know the latest trends and insights prevalent in the Medical Biomimetics market press release, click the link below: https://www.coherentmarketinsights.com/press-release/medical-biomimetics-market-3052
Key Takeaways of the Medical Biomimetics Market:
- The global medical biomimetics market is expected to exhibit a CAGR of 6.5% over the forecast period owing to the increasing use of biomemetics to treat breast cancer. For instance, according to reports published by the American Cancer Society in 2019, around 268,600 new cases of invasive breast cancer will be diagnosed in women, and the incidence rate has increased by 0.4% per year.
- Among technique, the wire guided localization technique segment is expected to witness significant CAGR in the global medical biomimetics market in 2020 owing to the establishment and higher adoption of biomemetics in healthcare industry.
- Among application, the cardiovascular segment held dominant position in the global medical biomimetics market in 2019 due to the increasing patient population and research and development of biomimetics to treat cardiovascular disorders; such as development of scaffold with biomimetic properties for treating aortic dysfunctions is expected to drive the market growth during the forecast period.
- Key players operating in the global medical biomimetics market are AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EP Endovascular AB, Varian Medical Systems, Inc., Abbott, Osteopore International Pte Ltd., and Applied Biomimetic.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027